A detailed history of Intech Investment Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Intech Investment Management LLC holds 201,873 shares of ABBV stock, worth $36.3 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares
201,873
Previous 280,847 28.12%
Holding current value
$36.3 Million
Previous $48.2 Million 17.24%
% of portfolio
0.46%
Previous 0.61%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$163.84 - $199.33 $12.9 Million - $15.7 Million
-78,974 Reduced 28.12%
201,873 $39.9 Million
Q2 2024

Aug 12, 2024

SELL
$154.79 - $180.76 $3.04 Million - $3.55 Million
-19,657 Reduced 6.54%
280,847 $48.2 Million
Q1 2024

May 10, 2024

SELL
$159.82 - $182.1 $46.9 Million - $53.5 Million
-293,747 Reduced 49.43%
300,504 $54.7 Million
Q4 2023

Oct 18, 2024

BUY
$137.6 - $154.97 $8.22 Million - $9.25 Million
59,718 Added 11.17%
594,251 $92.1 Million
Q4 2023

Feb 09, 2024

BUY
$137.6 - $154.97 $8.22 Million - $9.25 Million
59,718 Added 11.17%
594,251 $92.1 Million
Q3 2023

Oct 18, 2024

SELL
$133.59 - $154.65 $38 Million - $44 Million
-284,800 Reduced 34.76%
534,533 $79.7 Million
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $38.4 Million - $44.4 Million
-287,191 Reduced 34.95%
534,533 $79.7 Million
Q2 2023

Oct 18, 2024

SELL
$132.51 - $164.9 $26.7 Million - $33.2 Million
-201,127 Reduced 19.71%
819,333 $110 Million
Q2 2023

Aug 09, 2023

SELL
$132.51 - $164.9 $26.5 Million - $32.9 Million
-199,696 Reduced 19.55%
821,724 $111 Million
Q1 2023

Oct 18, 2024

BUY
$144.61 - $166.54 $107 Million - $123 Million
739,613 Added 263.35%
1,020,460 $163 Million
Q1 2023

May 10, 2023

BUY
$144.61 - $166.54 $17.2 Million - $19.8 Million
118,681 Added 13.15%
1,021,420 $163 Million
Q4 2022

Oct 18, 2024

SELL
$138.31 - $165.87 $7.94 Million - $9.52 Million
-57,397 Reduced 5.98%
902,739 $146 Million
Q4 2022

Feb 09, 2023

SELL
$138.31 - $165.87 $7.94 Million - $9.52 Million
-57,397 Reduced 5.98%
902,739 $146 Million
Q3 2022

Oct 18, 2024

BUY
$134.21 - $153.93 $91.2 Million - $105 Million
679,289 Added 241.87%
960,136 $129 Million
Q3 2022

Nov 10, 2022

BUY
$134.21 - $153.93 $5.11 Million - $5.87 Million
38,109 Added 4.13%
960,136 $129 Million
Q2 2022

Aug 10, 2022

BUY
$137.62 - $174.96 $127 Million - $161 Million
922,027 New
922,027 $141 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Intech Investment Management LLC Portfolio

Follow Intech Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.